Operating Lease, Liability in USD of Insight Molecular Diagnostics Inc. from Q3 2019 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Present value of lessee's discounted obligation for lease payments from operating lease.
Summary
Insight Molecular Diagnostics Inc. quarterly Operating Lease, Liability history and change rate from Q3 2019 to Q3 2025.
  • Insight Molecular Diagnostics Inc. Operating Lease, Liability for the quarter ending 30 Sep 2025 was $1.95M, a 31.1% decline year-over-year.
Operating Lease, Liability, Quarterly (USD)
Operating Lease, Liability, YoY Quarterly Change (%)

Insight Molecular Diagnostics Inc. Quarterly Operating Lease, Liability (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $1.95M -$882K -31.1% 30 Sep 2025 10-Q 10 Nov 2025
Q2 2025 $2.19M -$850K -28% 30 Jun 2025 10-Q 11 Aug 2025
Q1 2025 $2.41M 31 Mar 2025 10-Q 12 May 2025
Q4 2024 $2.63M 31 Dec 2024 10-K 24 Mar 2025
Q3 2024 $2.84M 30 Sep 2024 10-Q 12 Nov 2024
Q2 2024 $3.04M 30 Jun 2024 10-Q 08 Aug 2024
Q1 2021 $4.27M +$912K +27.2% 31 Mar 2021 10-Q 17 May 2021
Q3 2020 $3.93M +$3.54M +891% 30 Sep 2020 10-Q 12 Nov 2020
Q2 2020 $3.39M 30 Jun 2020 10-Q 29 Jul 2020
Q1 2020 $3.36M 31 Mar 2020 10-Q 12 May 2020
Q3 2019 $397K 30 Sep 2019 10-Q 14 Nov 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.